APSR2026-561

 
Late-Breaking
Submitted
Poster Presentation
 
AP14-055
P74
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1216446-46904-DUODENAL LUNG ADENOCA POSTER FINAL_440554.pdf
Format: PDF Only
08. Lung Cancer
6

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Nicole Chui-Jiet Fong * Hospital Queen Elizabeth Respiratory department Sabah Malaysia
Sunn-Ren Tee - Hospital Queen Elizabeth Respiratory department Sabah Malaysia
Rong Lih Ho - Hospital Queen Elizabeth Respiratory department Sabah Malaysia
Joon Hi Tham - Hospital Queen Elizabeth Pathology Department Sabah Malaysia
Hema Yamini Ramarmuty - Hospital Queen Elizabeth Respiratory department Sabah Malaysia
Kunji Kannan Sivaraman Kannan - Hospital Queen Elizabeth Respiratory department Sabah Malaysia
 
 
 
 
 
 
 
 
 
Presenting Author Details
Nicole Chui-Jiet
Fong
nicole.fong8246@gmail.com
+601119561128
Under 30
Malaysia
Case Report
Lung Adenocarcinoma Presenting as Duodenal Mass With Upper Gastrointestinal Bleeding: A Diagnostic Pitfall Confirmed by Immunohistochemistry and Next-Generation Sequencing
Maximum 25 words
Abstract Content
 
 
 
 
Lung adenocarcinoma most commonly metastasises to the liver, brain, adrenal glands and bone. Gastrointestinal involvement is uncommon, with duodenal involvement being particularly rare. Symptomatic presentation, especially in the form of upper gastrointestinal bleeding, is unusual and may mimic primary gastrointestinal malignancy. We report a case of primary lung adenocarcinoma that was identified following histopathological evaluation of a duodenal lesion.
A 67-year-old male non-smoker presented to the emergency department with a history of chronic cough and constitutional symptoms. During hospitalisation, he developed malaena. Oesophagogastroduodenoscopy revealed an almost circumferential hard mass seen at the first part of the duodenum (D1), classified as NICE type 3. Histopathological examination demonstrated poorly differentiated adenocarcinoma. Immunohistochemistry showed positivity for thyroid transcription factor-1 (TTF-1), consistent with metastatic pulmonary origin. Contrast-enhanced CT of the thorax, abdomen and pelvis demonstrated a large enhancing mass in the apicoposterior segment of the left upper lobe with pleural, nodal, adrenal and bony metastases. CT brain revealed two right frontal rim-enhancing lesions with vasogenic oedema, favouring intracranial metastases. Serum carcinoembryonic antigen was elevated (88.9 ng/ml). The diagnosis of stage IV lung adenocarcinoma with duodenal and brain metastases was established. Subsequent next-generation sequencing showed TP53 mutation, an EGFR mutation and MET amplification.
Small bowel metastasis from lung adenocarcinoma is rare and typically remains clinically silent until complications such as obstruction or bleeding occur. The endoscopic appearances are non-specific and can resemble primary duodenal carcinoma, posing a diagnostic challenge. This case highlights the pivotal role of immunohistochemistry in determining the primary tumour origin. Early recognition of such atypical presentation is essential for accurate staging, prognostication and timely initiation of appropriate systemic and molecular-targeted therapies.
 
 
Yes
No
 
JPG or JPEG or PNG format ONLY
Lung adenocarcinoma, Duodenal metastasis, Immunohistochemical markers
maximum 3 keywords and no abbreviations, separated by commas
The authors would like to express their sincere appreciation to all department staff for their involvement in the management of this patient.
271